RIVANNA Commences Sales of Accuro
Thursday, November 5, 2015
Rivanna Medical has begun selling its Accuro device to anesthesia providers as a result of a successful product launch at the annual meeting of the American Society of Anesthesiologists (ASA) in San Diego last week. The company is also continuing discussions with three potential corporate partners.
Accuro’s initial commercial application is designed to provide 3D navigation of the lumbar spine to automatically guide clinicians to a first-attempt success in administering spinal and epidural anesthesia.
“Anesthesia providers attending the recent ASA scientific meeting told us that Accuro fulfills a significant unmet clinical need for automated image guidance,” said John A. Williams, President and CEO, “especially in the spinal anesthesia sector.”
Williams explained that needle insertion for spinal and epidural anesthesia is a demanding procedure, especially for inexperienced physicians in general, and in particular in patients with high-BMI.
Data from a recently completed clinical study at the University of Virginia School of Medicine showed that Rivanna Medical’s Accuro device was 94% successful in automatically identifying the epidural space via its proprietary real-time 3D image automation technology, SpineNav3D™. The study’s principal investigator was Mohamed Tiouririne, MD, Dept. of Anesthesiology, University of Virginia School of Medicine.